
AIE is a spin-off of SAIA (an NGO), a world leader in AI biomedical applications. In the last 15 years, we developed the best non-invasive multi-cancer diagnosis and early detection test. It’s based on patients, advanced AI, and works on 13 cancers with >99% accuracy. It avoids patients’ fear, pain, and risks (liquid biopsy: drop of blood), dramatically increasing survival rate and decreasing treatment cost (more details here https://cordis.europa.eu/article/id/411554-artificial-intelligence-enhances-cancer-diagnostic-testing?WT.mc_id=exp). Our vision considers the paradigm shift biomedicine…
Annual Revenue$1M to $5M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.